Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/medicalconferences/wp-includes/functions.php on line 6114
Study reveals spectrum of COVID-19 brain complications - Medical Conferences

Home > Neurology > Study reveals spectrum of COVID-19 brain complications

Study reveals spectrum of COVID-19 brain complications

Conference
Radiological Society of North America annual meeting
Reuters Health - 30/11/2021 - Brain complications including stroke and hemorrhage occur in about one in 100 hospitalized patients with COVID-19, new research suggests.

"There should probably be a low threshold to order brain imaging for patients with COVID-19," lead investigator Dr. Scott Faro of Thomas Jefferson University, in Philadelphia, said in a statement from the Radiological Society of North America (RSNA) annual meeting, where he presented the study.

It's become clear that COVID-19 symptoms extend "well beyond the flu-like symptoms and devastating pulmonary involvement" and now include central nervous system (CNS) complications, he told attendees.

To get a better handle on CNS complications of COVID-19, he and his colleagues did a retrospective review of 37,950 patients (mean age, 66 years) who were hospitalized with COVID-19 at seven U.S. and four Western European university hospitals.

A total of 4,342 patients (11%) underwent neuroimaging and acute neuroimaging findings most likely associated with the viral infection were present in 442 patients (10%). The overall incidence of CNS complications was 1.2%.

Ischemic stroke was the most common finding (62.4%), followed by intracranial hemorrhage (37.1%), encephalitis (5.2%), sinus venous thrombosis (2.3%), acute demyelinating encephalomeningitis (1.8%), posterior reversible encephalopathy (1.6%) and vasculitis (0.5%).

Most patients had lesions on only one side of the brain (59.7%) and involving the frontal and parietal lobes (roughly 52%), with an equal distribution of white matter, cortical and subcortical involvement (about 55%).

"Much has been written about the overall pulmonary problems related to COVID-19, but we do not often talk about the other organs that can be affected. Our study shows that central nervous system complications represent a significant cause of morbidity and mortality in this devastating pandemic," Dr. Faro said in the statement.

SOURCE: https://bit.ly/3lifM9T Radiological Society of North America annual meeting, November 28 to December 2, 2021.



Posted on